Skip to content

Prospective clinical study of Jintiange capsule in the treatment of osteosarcopenia

Prospective clinical study of Jintiange capsule in the treatment of osteosarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006637
Enrollment
Unknown
Registered
2022-09-21
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia and osteoporosis

Interventions

Sponsors

The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Women with menopause = 1 year, and men = 60 years old; can cooperate with basic data collection, bone mineral density examination, body composition analysis and serological testing; voluntarily participate in this study and sign the informed consent. 2. Meet the diagnostic criteria for osteoporosis; 3. Meet the diagnostic criteria for sarcopenia 4. Meet the diagnostic criteria for TCM diagnosis of kidney deficiency syndrome.

Exclusion criteria

Exclusion criteria: Patients with serious cardiovascular, cerebrovascular, liver, kidney and other important organ diseases; patients with major diseases of the respiratory, digestive tract, urinary and other systems; patients with diseases affecting bone density and calcium and phosphorus metabolism; patients with malignant tumors; recent use Patients with drugs that affect bone metabolism and body composition; those who are too obese to undergo bone mineral density examination and body composition analysis; women who have undergone oophorectomy or total hysterectomy before menopause; suffer from neurological disorders that cause insight Those who lack; those who are illiterate and unable to answer lifestyle questionnaires and quality of life assessments; have participated in other academic researchers, etc.

Design outcomes

Primary

MeasureTime frame
Ga2+;N-terminal mid-molecular osteocalcin;SARC-CalF scale;Appendicular skeletal muscle mass index;Mean bone mineral density of the lumbar spine (L2-L4);Type I procollagen N-terminal propeptide;B-CTX;

Secondary

MeasureTime frame
fat index;Fat mass in each part;Fat percentage of each part;

Countries

China

Contacts

Public ContactHuang hongxing
gzhhx@126.com13922726488

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026